Role of KEAP1/NRF2 and TP53 Mutations in Lung Squamous Cell Carcinoma Development and Radiation Resistance.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Discovery

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1158/2159-8290.CD-16-0127PMID 27663899PMCID PMC5222718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Integrated digital error suppression for improved detection of circulating tumor DNA

  2016cited by this paper
• LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response.

  2015cited by this paper
• Antioxidants can increase melanoma metastasis in mice

  2015cited by this paper
• NRF2 Pathway Activation and Adjuvant Chemotherapy Benefit in Lung Squamous Cell Carcinoma

  2015cited by this paper
• Comprehensive genomic characterization of head and neck squamous cell carcinomas

  2015cited by this paper
• Xc- inhibitor sulfasalazine sensitizes colorectal cancer to cisplatin by a GSH-dependent mechanism.

  2015cited by this paper
• Lung stem cell differentiation in mice directed by endothelial cells via a BMP4-NFATc1-thrombospondin-1 axis.

  2014cited by this paper
• Genetic landscape of esophageal squamous cell carcinoma

  2014cited by this paper
• Cell migration leads to spatially distinct but clonally related airway cancer precursors

  2014cited by this paper
• Transdifferentiation of lung adenocarcinoma in mice with Lkb1 deficiency to squamous cell carcinoma

  2014cited by this paper
• Genomic and molecular characterization of esophageal squamous cell carcinoma

  2014cited by this paper
• The cell of origin and subtype of K-Ras-induced lung tumors are modified by Notch and Sox2

  2014cited by this paper
• Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients.

  2014cited by this paper
• Comprehensive molecular profiling of lung adenocarcinoma

  2014cited by this paper
• Comprehensive molecular characterization of urothelial bladder carcinoma

  2014cited by this paper
• p63+Krt5+ distal airway stem cells are essential for lung regeneration

  2014cited by this paper
• Role of PTEN in basal cell derived lung carcinogenesis

  2014cited by this paper
• YAP inhibits squamous transdifferentiation of Lkb1-deficient lung adenocarcinoma through ZEB2-dependent DNp63 repression

  2014cited by this paper
• Sox2 Cooperates with Lkb1 Loss in a Mouse Model of Squamous Cell Lung Cancer

  2014cited by this paper
• Dynamic changes in intracellular ROS levels regulate airway basal stem cell homeostasis through Nrf2-dependent Notch signaling.

  2014cited by this paper
• Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression.

  2014cited by this paper
• Antioxidants Accelerate Lung Cancer Progression in Mice

  2014cited by this paper
• The Involvement of NRF2 in Lung Cancer

  2013cited by this paper
• Nrf2 prevents initiation but accelerates progression through the Kras signaling pathway during lung carcinogenesis.

  2013cited by this paper
• Landscape of genomic alterations in cervical carcinomas

  2013cited by this paper
• Sox2 cooperates with inflammation-mediated Stat3 activation in the malignant transformation of foregut basal progenitor cells.

  2013cited by this paper
• Dedifferentiation of committed epithelial cells into stem cells in vivo

  2013influential reference
• An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

  2013cited by this paper
• Integrative radiogenomic profiling of squamous cell lung cancer.

  2013cited by this paper
• The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas.

  2013cited by this paper
• xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma.

  2013cited by this paper
• Comprehensive genomic characterization of squamous cell lung cancers

  2012cited by this paper
• Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers

  2012cited by this paper
• The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group.

  2012cited by this paper
• An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses.

  2012cited by this paper
• Select heterozygous Keap1 mutations have a dominant-negative effect on wild-type Keap1 in vivo.

  2011cited by this paper
• Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

  2011cited by this paper
• Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer

  2011cited by this paper
• Cell of origin of small cell lung cancer: inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung.

  2011cited by this paper
• Genetic Disruption of KEAP1/CUL3 E3 Ubiquitin Ligase Complex Components is a Key Mechanism of NF-KappaB Pathway Activation in Lung Cancer

  2011cited by this paper
• NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer.

  2011cited by this paper
• Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features

  2010cited by this paper
• Identification of a Cell of Origin for Human Prostate Cancer

  2010cited by this paper
• Isolation, cultivation and characterization of adult murine prostate stem cells

  2010cited by this paper
• Gain of Nrf2 Function in Non-Small-Cell Lung Cancer Cells Confers Radioresistance

  2010cited by this paper
• Airway basal stem cells: a perspective on their roles in epithelial homeostasis and remodeling

  2010cited by this paper
• Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma.

  2010cited by this paper
• Loss of Kelch-Like ECH-Associated Protein 1 Function in Prostate Cancer Cells Causes Chemoresistance and Radioresistance and Promotes Tumor Growth

  2010cited by this paper
• Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors.

  2010cited by this paper
• Regulation of Notch1 Signaling by Nrf2: Implications for Tissue Regeneration

  2010cited by this paper
• KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta.

  2009cited by this paper
• A robust and high-throughput Cre reporting and characterization system for the whole mouse brain

  2009cited by this paper
• Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase

  2009cited by this paper
• Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth.

  2008cited by this paper
• Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues.

  2008cited by this paper
• Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy

  2008cited by this paper
• The x  c− cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases

  2008cited by this paper
• Lung development and repair: Contribution of the ciliated lineage

  2007cited by this paper
• Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity.

  2006cited by this paper
• The differential effects of mutant p53 alleles on advanced murine lung cancer.

  2005influential reference
• Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance.

  2005cited by this paper
• From the Cover: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

  2005cited by this paper
• A Chemically Induced Model for Squamous Cell Carcinoma of the Lung in Mice

  2004cited by this paper
• Neoplasms of the skin and other organs observed in Swiss mice treated with nitrosoalkylureas

  2004cited by this paper
• Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2

  2004cited by this paper
• Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model.

  2003cited by this paper
• In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.

  2003influential reference
• Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population.

  2002cited by this paper
• Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer

  2001cited by this paper
• Evidence for stem-cell niches in the tracheal epithelium.

  2001cited by this paper
• Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain.

  1999cited by this paper
• Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.

  1997cited by this paper
• An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

  1997cited by this paper
• Radiobiology for the Radiologist

  1979cited by this paper

• Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt.

  2026cites this paper
• Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms.

  2026cites this paper
• FAM83A promotes the progression of lung squamous cell carcinoma by inducing the epithelial-mesenchymal transition and inhibiting apoptosis via ERK pathway.

  2026cites this paper
• NRF2 pathway activation and SPP1⁺TREM2⁺ macrophages drive chemoradiotherapy resistance in esophageal squamous cell carcinoma

  2026cites this paper
• Lineage plasticity and histological transformation: tumor histology as a spectrum

  2025cites this paper
• Targeting Nrf2 in acute myeloid leukemia: an updated review on its role in chemoresistance and emerging therapeutic strategies

  2025cites this paper
• Unveiling Novel Targets in Lung Tumors for Enhanced Radiotherapy Efficacy: A Comprehensive Review

  2025cites this paper
• Prediction of zoonotic virus-host transmissibility using comparative airway organoids

  2025cites this paper
• KLF4 promotes a KRT13+ hillock-like state in squamous lung cancer

  2025cites this paper
• In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer

  2025cites this paper
• Comparative survival analysis of stage T1-T2N0M0 lung squamous cell carcinoma and adenocarcinoma using SEER data, and nomogram analysis for early-stage lung squamous cell carcinoma

  2025cites this paper
• Tumor microenvironment in squamous cell lung cancer – histological and immunohistochemical study

  2025cites this paper
• Nrf2 hyperactivation as a driver of radiotherapy resistance and suppressed anti-tumor immunity in head and neck squamous cell carcinoma.

  2025cites this paper
• Microbial metabolites control self-renewal and precancerous progression of human cervical stem cells

  2025cites this paper
• Oxygen needs sulfur, sulfur needs oxygen: a relationship of interdependence

  2025cites this paper
• GDF15 Drives Glioblastoma Radioresistance by Inhibiting Ferroptosis and Remodeling the Immune Microenvironment

  2025cites this paper
• Resistance to Radiation Enhances Metastasis by Altering RNA Metabolism

  2025cites this paper
• TMPRSS11B promotes an acidified microenvironment and immune suppression in squamous lung cancer

  2025cites this paper
• The Role of Reductive Stress in the Pathogenesis of Endocrine-Related Metabolic Diseases and Cancer

  2025cites this paper
• Oncogenic Mutations and the Tumor Microenvironment: Drivers of Non-Small Cell Lung Cancer Progression

  2025cites this paper
• RNF217-KEAP1-NRF2 feedback loop confers therapeutic resistance by inhibiting ferroptosis in esophageal squamous cell carcinoma.

  2025cites this paper
• Refining treatment strategies for non-small cell lung cancer lacking actionable mutations: insights from multi-omics studies

  2025cites this paper
• NRF2 activation in cancer and overview of NRF2 small molecule inhibitors

  2025cites this paper
• Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy

  2025cites this paper
• Transmembrane Serine Protease TMPRSS11B promotes an acidified tumor microenvironment and immune suppression in lung squamous cell carcinoma

  2025cites this paper
• Ex vivo use of probe-based confocal laser endomicroscopy in lung cancer visualization: an ex vivo pilot study

  2025cites this paper
• Some new aspects of erastin-induced ferroptosis in cancer cells.

  2025cites this paper
• FAM83A is a prognostic biomarker for lung squamous cell carcinoma and correlated with immunoregulation

  2025cites this paper
• Impact of RAS-MAPK Pathway Genetic Alterations on Radiotherapy Response in Metastatic Lung Adenocarcinoma.

  2025cites this paper
• Decoding the NRF2–NOTCH Crosstalk in Lung Cancer—An Update

  2025cites this paper
• YAP/TEAD-activated TAG synthesis and peroxidation in lipid droplets confer ROS resistance in cancer stem cells

  2025cites this paper
• Health position paper and redox perspectives – Bench to bedside transition for pharmacological regulation of NRF2 in noncommunicable diseases

  2025cites this paper
• Preoperative chemoradiotherapy plus pembrolizumab for esophageal squamous cell carcinoma (ACTS-29)

  2025cites this paper
• The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunities

  2025cites this paper
• Resistance to radiation enhances metastasis by altering RNA metabolism

  2025cites this paper
• Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer.

  2025cites this paper
• Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer Models.

  2025cites this paper
• Rationale and design for a phase IIIb trial of first-line tremelimumab plus durvalumab versus pembrolizumab, in combination with chemotherapy, in patients with non-squamous metastatic non-small-cell lung cancer and mutations or co-mutations in STK11, KEAP1, or KRAS: the TRITON study

  2025cites this paper
• Involvement of KEAP1/NRF2 pathway in non‐BRAF mutated squamous cell carcinoma of the thyroid

  2025cites this paper
• A detailed insight into macrophages' role in shaping lung carcinogenesis.

  2024cites this paper
• A two-pronged approach to inhibit ferroptosis of MSCs caused by the iron overload in postmenopausal osteoporosis and promote osseointegration of titanium implant

  2024cites this paper
• Lung Cancer Organoid System to Evaluate the Cytotoxicity of Natural Killer Cells

  2024cites this paper
• Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin

  2024cites this paper
• The correlation between KRAS and TP53 gene mutations and early growth of pulmonary nodules

  2024cites this paper
• Distinct roles for the thioredoxin and glutathione antioxidant systems in Nrf2-Mediated lung tumor initiation and progression

  2024cites this paper
• The Complex Roles of Redox and Antioxidant Biology in Cancer.

  2024cites this paper
• Impacts of cytoplasmic p53 aggregates on the prognosis and the transcriptome in lung squamous cell carcinoma

  2024cites this paper
• Histology-driven hypofractionated radiation therapy schemes for early-stage lung adenocarcinoma and squamous cell carcinoma.

  2024cites this paper
• A novel dual ATM/DNA-PK inhibitor, XRD-0394, potently radiosensitizes and potentiates PARP and topoisomerase I inhibitors.

  2024cites this paper
• Exploring the NRF2‐TP53 Signaling Network Through Machine Learning and Pan‐Cancer Analysis: Identifying Potential targets for Cancer Prognosis Related to Oxidative Stress

  2024cites this paper
• Impact of LKB1 status on radiation outcome in patients with stage III non-small-cell lung cancer

  2024influential citation
• Differential squamous cell fates elicited by NRF2 gain of function versus KEAP1 loss of function.

  2024cites this paper
• Emerging mechanisms of ferroptosis and its implications in lung cancer

  2024cites this paper
• Atox1-cyclin D1 loop activity is critical for survival of tumor cells with inactivated TP53

  2024cites this paper
• A graphSAGE discovers synergistic combinations of Gefitinib, paclitaxel, and Icotinib for Lung adenocarcinoma management by targeting human genes and proteins: the RAIN protocol

  2024cites this paper
• Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer

  2024cites this paper
• Clinical perspectives on the value of testing for STK11 and KEAP1 mutations in advanced NSCLC

  2024cites this paper
• Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer.

  2024cites this paper
• CRL3Keap1 E3 ligase facilitates ubiquitin-mediated degradation of oncogenic SRX to suppress colorectal cancer progression

  2024cites this paper
• Imaging NRF2 activation in non-small cell lung cancer with positron emission tomography

  2024cites this paper
• New insights into crosstalk between Nrf2 pathway and ferroptosis in lung disease

  2024cites this paper
• Using 3-Dimensional Cultures to Propagate Genetically Modified Lung Organoids.

  2024cites this paper
• PET/CT-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non–Small Cell Lung Cancer Treated with Curative Radiotherapy

  2024cites this paper
• Vulnerability of Antioxidant Drug Therapies on Targeting the Nrf2-Trp53-Jdp2 Axis in Controlling Tumorigenesis

  2024cites this paper
• Landscape of targeted therapies for lung squamous cell carcinoma

  2024cites this paper
• KEAP1-mutant atypical meningioma: illustrative case

  2024cites this paper
• Identification of Molecular Subtypes and Prognostic Traits Based on Chromosomal Instability Phenotype-Related Genes in Lung Adenocarcinoma

  2024cites this paper
• Preoperative CT-based radiomic prognostic index to predict the benefit of postoperative radiotherapy in patients with non-small cell lung cancer: a multicenter study

  2024cites this paper
• A Genomic Score to Predict Local Control among Patients with Brain Metastases Managed with Radiation.

  2023cites this paper
• Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC

  2023cites this paper
• Radio-resistance of hypoxic tumors: exploring the effects of oxygen and X-ray radiation on non-small lung cancer cell lines

  2023cites this paper
• Stereotactic body radiation therapy in unresectable stage III non-small cell lung cancer: A systematic review.

  2023cites this paper
• Characterization and mechanisms of radioresistant lung squamous cell carcinoma cell lines

  2023cites this paper
• Nuclear Factor Erythroid 2-Related Factor 2/Kelch-Like ECH-Associated Protein 1 as a Predictor of Prognosis and Radiotherapy Resistance in Patients With Locally Advanced Rectal Cancer: A Prospective Analysis

  2023cites this paper
• Review: Mechanisms and perspective treatment of radioresistance in non-small cell lung cancer

  2023cites this paper
• A scientometrics and visualization analysis of oxidative stress modulator Nrf2 in cancer profiles its characteristics and reveals its association with immune response

  2023cites this paper
• NFE2L2 mutations enhance radioresistance in head and neck cancer by modulating intratumoral myeloid cells.

  2023cites this paper
• A narrative review of genetic biomarkers in non-small cell lung cancer: an update and future perspectives

  2023cites this paper
• Concurrent Mutations in STK11 and KEAP1 Cause Treatment Resistance in KRAS Wild-type Non-small-cell Lung Cancer

  2023cites this paper
• Nrf2, A Target for Precision Oncology in Cancer Prognosis and Treatment

  2023cites this paper
• Exploring the multifaceted role of NRF2 in brain physiology and cancer: A comprehensive review

  2023cites this paper
• Imaging the master regulator of the antioxidant response in non-small cell lung cancer with positron emission tomography

  2023cites this paper
• Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Durvalumab

  2023cites this paper
• Identifying patients suitable for targeted adjuvant therapy: advances in the field of developing biomarkers for tumor recurrence following irradiation

  2023cites this paper
• Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression

  2023cites this paper
• Tumor-immune microenvironment and NRF2 associate with clinical efficacy of PD-1 blockade combined with chemotherapy in lung squamous cell carcinoma

  2023cites this paper
• KEAP1/NRF2 Mutations in Stem Cells Define an Aggressive Subset of Head and Neck Cancer Patients Who Have a Poor Prognosis, Lung Metastasis, and Therapeutic Failure

  2023cites this paper
• Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled Trial.

  2023cites this paper
• Nestin overexpression reduces the sensitivity of gastric cancer cells to trastuzumab

  2023cites this paper
• Targeting mutant-p53 for cancer treatment: Are we there yet?

  2023cites this paper
• The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer

  2023cites this paper
• USP8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2.

  2023cites this paper
• Cancer Informatics for Cancer Centers: Sharing Ideas on How to Build an Artificial Intelligence–Ready Informatics Ecosystem for Radiation Oncology

  2023cites this paper
• A PI3K gene expression signature predicts for recurrence in early‐stage non–small cell lung cancer treated with stereotactic body radiation therapy

  2023influential citation
• A NRF2-induced secretory phenotype activates immune surveillance to remove irreparably damaged cells

  2023cites this paper
• Integrative multi-omic cancer profiling reveals DNA methylation patterns associated with therapeutic vulnerability and cell-of-origin.

  2023cites this paper
• Conditional dependency of LP-184 on prostaglandin reductase 1 is synthetic lethal in pancreatic cancers with DNA damage repair deficiencies.

  2023cites this paper
• Emerging Roles of Circulating Tumor DNA for Increased Precision and Personalization in Radiation Oncology.

  2023cites this paper
• Hedgehog

  2023cites this paper
• Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks

  2023influential citation